STANDARD BIOTOOLS INC. — Director's Dealing 2018

Jan 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2017-12-31

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-28	Common Stock	G	1800	—	Disposed	51245	Direct
2017-12-31	Common Stock	M	7848	—	Acquired	59093	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-31	Restricted Stock Units	$	M	7848	Disposed		Common Stock (7848.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5561	Indirect
Common Stock	53395	Indirect
Common Stock	3326	Indirect

Footnotes

F1: The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.

F3: Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017.